Neoplasms Metastasis Completed Phase 2 Trials for Bevacizumab (DB00112)

Also known as: Neoplasm Metastasis / Metastasis, Neoplasm

IndicationStatusPhase
DBCOND0066909 (Neoplasms Metastasis)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00116506Study of Bevacizumab, Erlotinib, FOLFOX for Patients With Untreated Metastatic Colorectal CancerTreatment
NCT00165568Using Positron Emission Tomography to Evaluate the Effects of Bevacizumab on Intra-tumoral Pharmacokinetics of 5-fluorouracil in Metastatic Colorectal CancerDiagnostic
NCT00447330Oxaliplatin, Capecitabine and Avastin for Metastatic Esophagogastric AdenocarcinomaTreatment